Changes in the gut bacterial communities in colon cancer surgery patients: an observational study.

Antimicrobial prophylaxis Colon cancer Colon surgery Gut microbiome

Journal

Gut pathogens
ISSN: 1757-4749
Titre abrégé: Gut Pathog
Pays: England
ID NLM: 101474263

Informations de publication

Date de publication:
04 Jan 2022
Historique:
received: 28 09 2021
accepted: 17 12 2021
entrez: 5 1 2022
pubmed: 6 1 2022
medline: 6 1 2022
Statut: epublish

Résumé

Colon surgery has been shown to modulate the intestinal microbiota. Our objective was to characterize these changes using state-of-the-art next generation sequencing techniques. We performed a single-centre prospective observational cohort study to evaluate the changes in the gut microbiota, i.e., taxon distribution, before and after elective oncologic colon surgery in adult patients with different antimicrobial prophylaxis regimens (standard prophylaxis with cefuroxime/metronidazole versus carbapenems for extended-spectrum beta-lactamase-producing Enterobacterales [ESBL-E] carriers). We obtained rectal samples on the day of surgery, intraoperative luminal samples, and rectal or stoma samples 3 days after surgery. We performed metataxonomic analysis based on sequencing of the bacterial 16S rRNA gene marker. Similarities and differences between bacterial communities were assessed using Bray-Curtis similarity, visualised using principal coordinates analysis and statistically tested by PERMANOVA. Comparison of taxa relative abundance was performed using ANCOM. We included 27 patients between March 27, 2019 and September 17, 2019. The median age was 63.6 years (IQR 56.4-76.3) and 44% were females. Most (81%) patients received standard perioperative prophylaxis as they were not ESBL carriers. There was no significant association between ESBL carriage and differences in gut microbiome. We observed large and significant increases in the genus Enterococcus between the preoperative/intraoperative samples and the postoperative sample, mainly driven by Enterococcus faecalis. There were significant differences in the postoperative microbiome between patients who received standard prophylaxis and carbapenems, specifically in the family Erysipelotrichaceae. This hypothesis-generating study showed rapid changes in the rectal microbiota following colon cancer surgery.

Sections du résumé

BACKGROUND BACKGROUND
Colon surgery has been shown to modulate the intestinal microbiota. Our objective was to characterize these changes using state-of-the-art next generation sequencing techniques.
METHODS METHODS
We performed a single-centre prospective observational cohort study to evaluate the changes in the gut microbiota, i.e., taxon distribution, before and after elective oncologic colon surgery in adult patients with different antimicrobial prophylaxis regimens (standard prophylaxis with cefuroxime/metronidazole versus carbapenems for extended-spectrum beta-lactamase-producing Enterobacterales [ESBL-E] carriers). We obtained rectal samples on the day of surgery, intraoperative luminal samples, and rectal or stoma samples 3 days after surgery. We performed metataxonomic analysis based on sequencing of the bacterial 16S rRNA gene marker. Similarities and differences between bacterial communities were assessed using Bray-Curtis similarity, visualised using principal coordinates analysis and statistically tested by PERMANOVA. Comparison of taxa relative abundance was performed using ANCOM.
RESULTS RESULTS
We included 27 patients between March 27, 2019 and September 17, 2019. The median age was 63.6 years (IQR 56.4-76.3) and 44% were females. Most (81%) patients received standard perioperative prophylaxis as they were not ESBL carriers. There was no significant association between ESBL carriage and differences in gut microbiome. We observed large and significant increases in the genus Enterococcus between the preoperative/intraoperative samples and the postoperative sample, mainly driven by Enterococcus faecalis. There were significant differences in the postoperative microbiome between patients who received standard prophylaxis and carbapenems, specifically in the family Erysipelotrichaceae.
CONCLUSION CONCLUSIONS
This hypothesis-generating study showed rapid changes in the rectal microbiota following colon cancer surgery.

Identifiants

pubmed: 34983654
doi: 10.1186/s13099-021-00477-7
pii: 10.1186/s13099-021-00477-7
pmc: PMC8729125
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2

Subventions

Organisme : Hôpitaux Universitaires de Genève
ID : PRD 21-2018-II

Informations de copyright

© 2022. The Author(s).

Références

BMJ Open. 2020 Jan 7;10(1):e031472
pubmed: 31915159
Antimicrob Resist Infect Control. 2019 May 22;8:83
pubmed: 31139366
Clin Colon Rectal Surg. 2011 Dec;24(4):283-90
pubmed: 23204944
Infect Control Hosp Epidemiol. 2019 Sep;40(9):983-990
pubmed: 31218977
Surg Endosc. 2016 Jun;30(6):2259-65
pubmed: 26385781
Surg Today. 2018 Mar;48(3):338-345
pubmed: 28948367
Clin Infect Dis. 2019 May 2;68(10):1699-1704
pubmed: 30204851
Biosci Microbiota Food Health. 2016;35(2):77-87
pubmed: 27200261
Sci Rep. 2019 Nov 5;9(1):16072
pubmed: 31690798
Int J Syst Evol Microbiol. 2017 May;67(5):1613-1617
pubmed: 28005526
BMC Surg. 2017 Dec 4;17(1):125
pubmed: 29202875
Infect Control Hosp Epidemiol. 2019 May;40(5):590-596
pubmed: 30786943
Appl Environ Microbiol. 2009 Dec;75(23):7537-41
pubmed: 19801464
Nat Rev Microbiol. 2016 Jan;14(1):20-32
pubmed: 26499895
Infect Control Hosp Epidemiol. 2017 Jun;38(6):697-704
pubmed: 28558862
Nat Methods. 2013 Oct;10(10):996-8
pubmed: 23955772
BMC Surg. 2021 Feb 12;21(1):83
pubmed: 33579260
Clin Infect Dis. 2021 Nov 2;73(9):e2754-e2762
pubmed: 33097951
Lancet Infect Dis. 2016 Dec;16(12):e276-e287
pubmed: 27816413
Am J Infect Control. 2016 Apr 1;44(4):450-4
pubmed: 27038393
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
Front Oncol. 2020 Nov 25;10:526009
pubmed: 33324541
BMC Microbiol. 2017 Mar 31;17(1):78
pubmed: 28359329
J Gastrointest Surg. 2020 Jul;24(7):1663-1672
pubmed: 32323252
World J Gastroenterol. 2019 Sep 14;25(34):5017-5025
pubmed: 31558854
Infect Control Hosp Epidemiol. 2014 Jun;35(6):660-6
pubmed: 24799642
Clin Nutr. 2017 Jun;36(3):623-650
pubmed: 28385477
Microbiome. 2014 Sep 15;2:35
pubmed: 25250176
Transl Res. 2021 Jan;227:75-88
pubmed: 32711187
Microb Ecol Health Dis. 2015 May 29;26:27663
pubmed: 26028277
Bioinformatics. 2014 Mar 1;30(5):614-20
pubmed: 24142950
Dis Colon Rectum. 2019 Sep;62(9):1105-1116
pubmed: 31318772
Euro Surveill. 2018 Nov;23(46):
pubmed: 30458912
Br J Surg. 2012 Apr;99(4):589-95
pubmed: 22231649
Biometrics. 2006 Mar;62(1):245-53
pubmed: 16542252
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):43-54
pubmed: 27729657
Ann Surg. 2019 May;269(5):911-916
pubmed: 29303807
Surg Endosc. 2013 Dec;27(12):4574-80
pubmed: 23996329
J Gastrointest Surg. 2013 Sep;17(9):1657-64
pubmed: 23807702
Surgery. 2007 Nov;142(5):704-11
pubmed: 17981191

Auteurs

Mohamed Abbas (M)

Infection Control Programme, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland. mohamed.abbas@hcuge.ch.

Nadia Gaïa (N)

Genomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Geneva, Switzerland.

Nicolas C Buchs (NC)

Division of Digestive Surgery, Geneva University Hospitals, Geneva, Switzerland.

Vaihere Delaune (V)

Division of Digestive Surgery, Geneva University Hospitals, Geneva, Switzerland.

Myriam Girard (M)

Genomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Geneva, Switzerland.

Diego O Andrey (DO)

Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.

Jeremy Meyer (J)

Division of Digestive Surgery, Geneva University Hospitals, Geneva, Switzerland.

Jacques Schrenzel (J)

Genomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Geneva, Switzerland.
Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
Laboratory of Bacteriology, Geneva University Hospitals, Geneva, Switzerland.

Frédéric Ris (F)

Division of Digestive Surgery, Geneva University Hospitals, Geneva, Switzerland.

Stephan Harbarth (S)

Infection Control Programme, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.

Vladimir Lazarevic (V)

Genomic Research Laboratory, Division of Infectious Diseases, University Hospitals and University of Geneva, Geneva, Switzerland.

Classifications MeSH